Tumourigenesis in experimental models is associated with the formation
of new blood vessels (angiogenesis). Recent studies have suggested th
at tumour angiogenic activity may be inferred in histological sections
by measuring the density of the vasculature. The purpose of this stud
y was to determine whether the transition from normal to dysplastic an
d neoplastic tissue in the oral mucosa is accompanied by quantitative
or qualitative changes in the vascularity of the tissue, and hom the e
stimate of vascularity is influenced by the vessel marker and method o
f assessment, A total of 100 specimens of normal oral mucosa, dysplast
ic lesions, and squamous cell carcinomas mere examined. Sections were
immunostained with the pan-endothelial antibodies to von Willebrand Fa
ctor (VWF) and CD31, or with an antibody to the alpha(v) beta(3) integ
rin, previously reported to be a marker of angiogenic vessels. Vascula
rity Nas quantitated by tao different methods: highest microvascular d
ensity (h-MVD) and microvascular volume, as determined by point counti
ng (MVV). The results showed that vascularity, measured by the MVV met
hod using antibodies to either vWF or CD31, increased significantly (P
<0.0001) with disease progression from normal oral mucosa, through mil
d, moderate, and severe dysplasia to early and late carcinoma (76 para
ffin-embedded tissues examined), In contrast, h-MVD did not discrimina
te between dysplastic lesions and carcinoma. A similar percentage of t
he total vessel volume (MVV) and density (h-MVD) were positive for alp
ha(v) beta(3) in 24 frozen tissues examined, including normal oral muc
osa. It is concluded that there is a close association between vascula
rity and tumour progression in the oral mucosa. Morphometric analysis
reflecting microvascular volume is more informative than the currently
popular analysis of microvascular density, The expression of alpha(v)
beta(3) in the vasculature of oral tissues does not necessarily refle
ct the presence of angiogenic vessels. (C) 1997 by John Wiley & Sons,
Ltd.